National Health Service

AliveCor's KardiaMobile® 6L Becomes First Personal ECG Device Recommended for Use in Psychiatric Services in England and Wales

Retrieved on: 
Tuesday, September 26, 2023

1, 2 KardiaMobile 6L is a portable ECG recording device that provides instant detection of cardiac abnormalities and can be used to measure heart changes including cardiac QT interval.1

Key Points: 
  • 1, 2 KardiaMobile 6L is a portable ECG recording device that provides instant detection of cardiac abnormalities and can be used to measure heart changes including cardiac QT interval.1
    "Timely ECG monitoring of patients who are on antipsychotic medication can save lives.
  • Having access to KardiaMobile 6L will mean potentially vulnerable patients can now be seen in the comfort of their homes, reducing their stress whilst ensuring that this essential monitoring is completed anywhere, at any time.
  • KardiaMobile 6L has been recommended as part of NICE's EVA pilot project, created to drive earlier access to promising healthcare innovations for use within the National Health Service in England and Wales.
  • "We have a wealth of clinical data on the use of KardiaMobile 6L in cardiology, with NICE's EVA recommendation we will now support the collection of real-world evidence as to its effectiveness in psychiatric services.

Ordr Partners with e-Quip to Deliver Improved Connected Medical Device Visibility and Security for UK Healthcare Market

Retrieved on: 
Tuesday, September 26, 2023

SANTA CLARA, Calif. and STAFFORD, England, Sept. 26, 2023 /PRNewswire/ -- Ordr, the leader in connected device security, today announced it has partnered with the UK's leading medical device asset management provider Integra e-Quip Ltd. The two companies have teamed up to deliver a best-in-class clinical asset management and security solution to healthcare organizations throughout the UK.

Key Points: 
  • The two companies have teamed up to deliver a best-in-class clinical asset management and security solution to healthcare organizations throughout the UK.
  • Ordr announced it has partnered with the UK's leading medical device asset management provider Integra e-Quip.
  • Ordr's AI-powered platform automatically discovers and classifies all devices connecting to a network, including IoMT (Internet of Medical Things) devices.
  • For more information about how Ordr and e-Quip can help your organization discover and secure every connected medical device, please click here .

Ordr Partners with e-Quip to Deliver Improved Connected Medical Device Visibility and Security for UK Healthcare Market

Retrieved on: 
Tuesday, September 26, 2023

SANTA CLARA, Calif. and STAFFORD, England, Sept. 26, 2023 /PRNewswire/ -- Ordr, the leader in connected device security, today announced it has partnered with the UK's leading medical device asset management provider Integra e-Quip Ltd. The two companies have teamed up to deliver a best-in-class clinical asset management and security solution to healthcare organizations throughout the UK.

Key Points: 
  • The two companies have teamed up to deliver a best-in-class clinical asset management and security solution to healthcare organizations throughout the UK.
  • e-Quip's Computerised Maintenance Management System (CMMS) maintains an inventory of all connected medical devices on a network, orchestrating critical processes such as device maintenance, procurement planning, and compliance assurance.
  • Ordr's AI-powered platform automatically discovers and classifies all devices connecting to a network, including IoMT (Internet of Medical Things) devices.
  • For more information about how Ordr and e-Quip can help your organization discover and secure every connected medical device, please click here .

Weight-loss Programs Level Up With Smart Wearable Devices

Retrieved on: 
Friday, September 15, 2023

NEW YORK, Sept. 15, 2023 /PRNewswire/ -- The wearable technology market has evolved in recent years into a major tech segment, in large part thanks to consumer market growth which is driven by sales of smartwatches. Major companies like Apple and Samsung are heavily involved in the innovation of wearable devices, which are now capable of performing a wide range of features including cellular connectivity, health monitoring, contactless payment and more. Due to the advanced health monitoring features found in the devices, the wearable technology market is now playing an important role in the medical sector as well. In recent years, the devices have allowed healthcare providers to remotely monitor a patient's various physiological parameters. The most commonly measured data include vital signs such as heart rate, blood pressure, number of calories burned during a day, sleep quality and oxygen level in the blood. Nemaura Medical Inc. (NASDAQ: NMRD), Planet Fitness, Inc. (NYSE: PLNT), WW International, Inc. (NASDAQ: WW), Garmin Ltd. (NYSE: GRMN), iRhythm Technologies, Inc. (NASDAQ: IRTC)

Key Points: 
  • Due to the advanced health monitoring features found in the devices, the wearable technology market is now playing an important role in the medical sector as well.
  • In recent years, the devices have allowed healthcare providers to remotely monitor a patient's various physiological parameters.
  • Nemaura Medical Inc. (NASDAQ: NMRD) announced breaking news earlier this week regarding, "interim results from its metabolic health program.
  • The high medical needs designation in Japan is granted to innovative devices recognized as having high medical utility for significant diseases.

Weight-loss Programs Level Up With Smart Wearable Devices

Retrieved on: 
Friday, September 15, 2023

NEW YORK, Sept. 15, 2023 /PRNewswire/ -- The wearable technology market has evolved in recent years into a major tech segment, in large part thanks to consumer market growth which is driven by sales of smartwatches. Major companies like Apple and Samsung are heavily involved in the innovation of wearable devices, which are now capable of performing a wide range of features including cellular connectivity, health monitoring, contactless payment and more. Due to the advanced health monitoring features found in the devices, the wearable technology market is now playing an important role in the medical sector as well. In recent years, the devices have allowed healthcare providers to remotely monitor a patient's various physiological parameters. The most commonly measured data include vital signs such as heart rate, blood pressure, number of calories burned during a day, sleep quality and oxygen level in the blood. Nemaura Medical Inc. (NASDAQ: NMRD), Planet Fitness, Inc. (NYSE: PLNT), WW International, Inc. (NASDAQ: WW), Garmin Ltd. (NYSE: GRMN), iRhythm Technologies, Inc. (NASDAQ: IRTC)

Key Points: 
  • Due to the advanced health monitoring features found in the devices, the wearable technology market is now playing an important role in the medical sector as well.
  • In recent years, the devices have allowed healthcare providers to remotely monitor a patient's various physiological parameters.
  • Nemaura Medical Inc. (NASDAQ: NMRD) announced breaking news earlier this week regarding, "interim results from its metabolic health program.
  • The high medical needs designation in Japan is granted to innovative devices recognized as having high medical utility for significant diseases.

'It is impossible for me to be unpaid': 3 ways to fix student work placements

Retrieved on: 
Saturday, September 16, 2023

So far, the Universities Accord’s interim report has identified compulsory, unpaid work placements as a significant barrier.

Key Points: 
  • So far, the Universities Accord’s interim report has identified compulsory, unpaid work placements as a significant barrier.
  • Students often must take time out of paid work for these placements which can take place over multi-week blocks away from home.

What are work placements?

    • Many professional courses, such as nursing, teaching, social work, psychology and the allied health professions, have significant work placement requirements.
    • For example, social work students need to complete 1,000 hours (nearly half a year) of full-time, unpaid work experience to graduate.
    • These placements are hugely important for student learning, but the time commitment means students often have to give up paid work.

1. Change the Fair Work Act

    • A further 43% of educators said organisations refused to host a student if they didn’t perform well during a pre-placement interview.
    • This means organisations are routinely screening students to ensure they can perform unpaid work while on placement.
    • To fix this, we recommend the federal parliament changes the Fair Work Act, so vocational placements must be paid.

2. Pay students a minimum wage

    • Despite the importance of paying students at least a minimum wage, it is clear the organisations they work for cannot pay.
    • There is no country in the world where universities pay students to do placements.
    • Calculated at the minimum wage rate (before the recent minimum wage increase), Unions NSW estimated students should earn around A$21,000 for a placement.
    • Read more:
      Fair Work Commission gives a 5.2% – $40 a week – increase in the minimum wage

3. Change how learning is measured

    • As one educator told us:
      [These] showed that students could achieve success in their placement and learning with less time and more flexibility.
    • One practitioner said:
      More focus on demonstrating learning as opposed to just ‘ticking off hours’ could lead to shorter placements with a higher focus on the quality of learning.
    • More focus on demonstrating learning as opposed to just ‘ticking off hours’ could lead to shorter placements with a higher focus on the quality of learning.

What about learning?

    • While current standards are often presumed to produce competent and ethical practitioners, our research shows students are being financially stretched and stressed.
    • Reflecting on their student experience, one practitioner told us:
      For me it became just getting the hours done, rather than learning.
    • In addition to payment, research shows that reducing hours, and introducing more flexible work-based placements and ways to measure learning, would help.

Nemaura Medical Provides Update on Nasdaq Compliance Status and Process

Retrieved on: 
Thursday, September 14, 2023

LOUGHBOROUGH, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc .

Key Points: 
  • LOUGHBOROUGH, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc .
  • (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today provided an update regarding the status of its compliance with Nasdaq continued listed standards and anticipated next steps to maintain its listing on The Nasdaq Capital Market.
  • The Company plans to timely request such hearing and is considering all options available to it to regain compliance and maintain its listing on The Nasdaq Capital Market.
  • Dr Faz Chowdhury, the Company’s Chief Executive Officer, commented, “We are hopeful that there will be a positive outcome from a hearing before the Panel.

Riverbed Launches New Energy Efficiency Capabilities to Alluvio Aternity Solution to Drive a Sustainable Digital Workplace

Retrieved on: 
Tuesday, September 12, 2023

Riverbed, the leader in unified observability, today announced new energy efficiency capabilities through its leading digital experience management (DEM) solution, Alluvio Aternity.

Key Points: 
  • Riverbed, the leader in unified observability, today announced new energy efficiency capabilities through its leading digital experience management (DEM) solution, Alluvio Aternity.
  • View the full release here: https://www.businesswire.com/news/home/20230912720468/en/
    Riverbed launches new energy efficiency capabilities to Alluvio Aternity solution to drive a sustainable digital workplace.
  • (Graphic: Business Wire)
    LinkedIn: Riverbed launches new energy efficiency capabilities to Alluvio Aternity to drive a sustainable digital workplace: https://rvbd.ly/3PaLT9L
    Aternity captures and correlates granular, actual end-user performance data from all applications and devices, translating it into actionable, environmental insights to reduce carbon emissions.
  • For more information on the Alluvio Aternity energy efficiency capabilities, available in September, visit: https://www.riverbed.com/sustainable-it

Ora, Inc. Featured in NHS 75: Celebrating 75 Years of the National Health Service

Retrieved on: 
Wednesday, September 6, 2023

Ora, Inc. , the world’s leading Clinical Research Organisation (CRO) for ophthalmology pharmaceutical and device development, announced today its inclusion in the NHS 75: Celebrating 75 Years of the National Health Service (NHS) book, launching today at the Palace of Westminster.

Key Points: 
  • Ora, Inc. , the world’s leading Clinical Research Organisation (CRO) for ophthalmology pharmaceutical and device development, announced today its inclusion in the NHS 75: Celebrating 75 Years of the National Health Service (NHS) book, launching today at the Palace of Westminster.
  • “It's an honour to be a part of this milestone event for the NHS,” said Stuart Abelson, CEO, Ora, Inc. “The National Health Service has delivered and innovated world leading healthcare throughout England for 75 years.
  • Richard Freed, founder of St James’s House, said: “We are delighted to be launching this fantastic book heralding all that is great about the National Health Service.
  • The 75th anniversary offers the perfect opportunity to reflect on the past, present, and future of the NHS.”

INmune Bio Inc. Announces Approval of Clinical Trial Application by the U.K. Medicines and Healthcare Products Regulatory Agency for Phase 2 Clinical Trial in Alzheimer’s Disease

Retrieved on: 
Tuesday, September 5, 2023

Boca Raton, Florida, Sept. 05, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today received authorization of its Clinical Trial Application (CTA) by the Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase 2 trial in Early Alzheimer’s disease (AD) with XPro™. The U.K. CTA is part of the Company’s international clinical development strategy for XPro™ in patients with early AD. The trial is also enrolling patients in Australia and Canada.

Key Points: 
  • The U.K. CTA is part of the Company’s international clinical development strategy for XPro™ in patients with early AD.
  • The AD02 Phase 2 clinical trial is a global, multi-center, randomized clinical study in patients diagnosed with early Alzheimer's disease.
  • In a prior Phase I open-lab trial, INmune Bio met all primary and secondary endpoints.
  • "We believe that the United Kingdom serves as an optimal setting for conducting clinical studies on Alzheimer's disease.